Metabolomic profiling could allow identification of cancer subtypes and precision therapy.
Browsing: Disease Area > Breast
Researchers have demonstrated the feasibility of utilizing tumor sequencing when guiding chemotherapy in early-breast cancer patients.
To mark Triple-Negative Breast Cancer Day, take a look at our new and exclusive summary infographic presenting some of the key facts about triple-negative breast cancer.
Researchers have discovered a novel biomarker that may predict poor prognosis in African-American triple-negative breast cancer patients.
In this article the authors discuss how extensive biobanking for each individual patient with subsequent genome sequencing can open novel horizons for precision medicine in breast cancer.
Researchers have uncovered a method of selectively labelling cancer cells which they hope will yield novel treatment options for cancers such as triple-negative breast cancer.
A novel study highlights the levels and trends of adjuvant endocrine therapy usage in hormone-sensitive breast cancer.
Findings presented at the 2017 European Cancer Congress (27–30 January, Amsterdam, The Netherlands) have demonstrated that breast conserving therapy could be more beneficial than mastectomy in certain breast cancer types.
New research finds that woman over 50 years of age who have been treated for ductal carcinoma in situ are as likely or even more likely to be alive 10 years later than women in the general population.